Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vidhya Karivedu

Showing results (11-20 of 20) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 20 results.
Oral Oncology|January 9, 2019
High-risk pathological features at the time of salvage surgery predict poor survival after definitive therapy in patients with head and neck squamous cell carcinomaSulsal Haque, Vidhya Karivedu, Muhammed K Riaz, et al.
Journal of Neuro-Oncology|November 20, 2016
Longitudinal experience with WHO Grade III (anaplastic) meningiomas at a single institutionSuresh K Balasubramanian, Mayur Sharma, Danilo Silva, et al.
Cancer Research Communications|May 16, 2025
Phase II Study Evaluating the Efficacy of Niraparib and Dostarlimab (TSR-042) in Patients with Recurrent/Metastatic Head and Neck Squamous Cell CarcinomaOlga Zamulko, Vidhya Karivedu, Muhammad Kashif Riaz, et al.
Journal for Immunotherapy of Cancer|November 3, 2022
Metformin increases natural killer cell functions in head and neck squamous cell carcinoma through CXCL1 inhibitionMcKenzie Crist, Benyamin Yaniv, Sarah Palackdharry, et al.
Cancers|September 5, 2020
Identification of Clinical and Socioeconomic Predictors of Adjuvant Therapy after Trans-Oral Robotic Surgery in Patients with Oropharyngeal Squamous Cell CarcinomaSujith Baliga, Brett Klamer, Sachin Jhawar, et al.
International Journal of Molecular Sciences|December 23, 2022
Association between Tumor Microbiome and Hypoxia across Anatomic Subsites of Head and Neck CancersAastha Dhakal, Rituraj Upadhyay, Caroline Wheeler, et al.
Frontiers in Oncology|December 13, 2021
Multi-Institutional Study Validates Safety of Intraoperative Cesium-131 Brachytherapy for Treatment of Recurrent Head and Neck CancerAdam Luginbuhl, Alyssa Calder, David Kutler, et al.
BMC Cancer|July 14, 2022
Update of a prognostic survival model in head and neck squamous cell carcinoma patients treated with immune checkpoint inhibitors using an expansion cohortMajd Issa, Brett G Klamer, Nikol Mladkova, et al.
Oncology Research and Treatment|September 13, 2021
Treatment Outcomes of Head and Neck Cancer Patients in the Elderly Receiving Different Chemoradiation Combinations: A Single-Center ExperienceVidhya Karivedu, Marcelo Bonomi, Majd Issa, et al.
Cancer Biology & Therapy|May 9, 2024
Comparative analysis of the tumor microbiome, molecular profiles, and immune cell abundances by HPV status in mucosal head and neck cancers and their impact on survivalRituraj Upadhyay, Aastha Dhakal, Caroline Wheeler, et al.
Pageof 2

Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Oral Oncology|January 9, 2019
High-risk pathological features at the time of salvage surgery predict poor survival after definitive therapy in patients with head and neck squamous cell carcinomaSulsal Haque, Vidhya Karivedu, Muhammed K Riaz, et al.
Journal of Neuro-Oncology|November 20, 2016
Longitudinal experience with WHO Grade III (anaplastic) meningiomas at a single institutionSuresh K Balasubramanian, Mayur Sharma, Danilo Silva, et al.
Cancer Research Communications|May 16, 2025
Phase II Study Evaluating the Efficacy of Niraparib and Dostarlimab (TSR-042) in Patients with Recurrent/Metastatic Head and Neck Squamous Cell CarcinomaOlga Zamulko, Vidhya Karivedu, Muhammad Kashif Riaz, et al.
Journal for Immunotherapy of Cancer|November 3, 2022
Metformin increases natural killer cell functions in head and neck squamous cell carcinoma through CXCL1 inhibitionMcKenzie Crist, Benyamin Yaniv, Sarah Palackdharry, et al.
Cancers|September 5, 2020
Identification of Clinical and Socioeconomic Predictors of Adjuvant Therapy after Trans-Oral Robotic Surgery in Patients with Oropharyngeal Squamous Cell CarcinomaSujith Baliga, Brett Klamer, Sachin Jhawar, et al.
International Journal of Molecular Sciences|December 23, 2022
Association between Tumor Microbiome and Hypoxia across Anatomic Subsites of Head and Neck CancersAastha Dhakal, Rituraj Upadhyay, Caroline Wheeler, et al.
Frontiers in Oncology|December 13, 2021
Multi-Institutional Study Validates Safety of Intraoperative Cesium-131 Brachytherapy for Treatment of Recurrent Head and Neck CancerAdam Luginbuhl, Alyssa Calder, David Kutler, et al.
BMC Cancer|July 14, 2022
Update of a prognostic survival model in head and neck squamous cell carcinoma patients treated with immune checkpoint inhibitors using an expansion cohortMajd Issa, Brett G Klamer, Nikol Mladkova, et al.
Oncology Research and Treatment|September 13, 2021
Treatment Outcomes of Head and Neck Cancer Patients in the Elderly Receiving Different Chemoradiation Combinations: A Single-Center ExperienceVidhya Karivedu, Marcelo Bonomi, Majd Issa, et al.
Cancer Biology & Therapy|May 9, 2024
Comparative analysis of the tumor microbiome, molecular profiles, and immune cell abundances by HPV status in mucosal head and neck cancers and their impact on survivalRituraj Upadhyay, Aastha Dhakal, Caroline Wheeler, et al.
Pageof 2